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Abstract: Spider venoms constitute incredibly diverse libraries of compounds, many of which are
involved in prey capture and defence. Polyamines are often prevalent in the venom and target
ionotropic glutamate receptors. Here we show that a novel spider polyamine, PA366, containing
a hydroxyphenyl-based structure is present in the venom of several species of tarantula, and has
selective toxicity against MCF-7 breast cancer cells. By contrast, a polyamine from an Australian
funnel-web spider venom, which contains an identical polyamine tail to PA366 but an indole-based
head-group, is only cytotoxic at high concentrations. Our results suggest that the ring structure plays
a role in the cytotoxicity and that modification to the polyamine head group might lead to more
potent and selective compounds with potential as novel cancer treatments.
Keywords: spider venom; NMR spectroscopy; polyamine; cancer; cytotoxicity
1. Introduction
The discovery of new compounds from nature is still one of the most efficient methods for finding
lead molecules for the development of pharmaceuticals [1,2]. These new compounds range from small
molecules to large biologics, and several approaches have facilitated their discovery. Screening using
NMR spectroscopy and recent advances in metabolomics have been valuable for characterising novel
small molecules, whereas advances in genomics and proteomics, as well as high-throughput screening
approaches are providing novel methods for the discovery of peptides and proteins [3,4].
In nature, venomous creatures are a rich source of new bioactive compounds. In particular, spider
venoms have enormous compound diversity, much of which has yet to be explored. More than four
million compounds are estimated to be present in the venom of the 46,000 different spider species [5,6].
Spider venom components are present for prey capture and defence purposes; however, some venom
compounds have been shown to have therapeutic potential, such as in the treatment of pain and
inflammation [7]. While the majority of compounds present in spider venoms are disulfide-rich
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peptides [5], small molecules such as the sulfated nucleosides found in brown recluse spiders [8] and
polyamines, found in many spider species (reviewed in [9]), are also present.
Polyamines are cationic compounds widespread throughout nature and are found in both
prokaryotic and eukaryotic organisms. They can modulate a range of cellular processes that include
cell proliferation, signalling and ion channel function [10]. The biological activities of polyamines are
mediated through interaction with anionic molecules including DNA, RNA and proteins. However,
such structural diversity exists amongst the polyamines that some have been shown to be involved
in tumorigenesis [11], and some have shown potential in treating diseases such as cancer [12].
Polyamines with potential for treating diseases include examples from marine sponges and fungi that
inhibit carbonic anhydrase IX, a cancer drug target [13]. One study that showed the conjugation
of certain polyamines to chloramphenicol enhanced anti-cancer and anti-bacterial activity [14].
The polyamine toxins present in spider venoms are part of a sub-class of polyamines characterised
by an aromatic head group with a polyamine chain that can block ionotropic glutamate (iGlu)
receptors [12,15]. These receptors have been considered as promising drug targets for neurological
and psychiatric disorders [16].
Using a combination of NMR and bioassay screening, we have identified and characterised a
novel polyamine (PA366) present in a range of tarantula (Theraphosidae) venoms. PA366 contains
a hydroxyphenyl-based aromatic head group and has more potent cytotoxicity against MCF-7
breast cancer cells than SK-MEL-28 melanoma or neonatal foreskin fibroblast (NFF) primary cells.
Potential protein binding interactions were probed using protein array analysis to investigate the
mechanism of action, and a comparison with an indole-based polyamine from Australian funnel-web
spider venom provided insight into the structure/function relationships.
2. Results
2.1. Cytotoxicity Assays and Characterisation of Bioactive Compound
Crude venoms from female specimens of 31 species of tarantula (Theraphosidae) were screened for
activity against the MCF-7 breast cancer cell line. Crude venom from funnel web spiders (male Sydney
Funnel-web spider (Atrax robustus), female Hadronyche valida, Hadronyche cerberea and Hadronyche
infensa- including species variants), and the wolf spider Hogna carolinensis, was also tested to allow
comparison with venom from two other families (Hexathelidae and Lycosidae). Substantial cytotoxicity
activity (defined as greater than 50% decrease in absorbance relative to the negative control) was
observed for 17 of the species tested including examples from all three families tested (see Table S1 for
the complete list of species screened). The cytotoxicity observed with crude female Phlogius sp. spider
venom is shown in Figure 1A.
Venom from eight species that displayed cytotoxicity were chosen for further study based on
availability of sample, and are listed in Table 1. Crude venom from these eight species were fractionated
using reversed-phase high performance liquid chromatography (RP-HPLC), and one-minute fractions
were collected. The fractions were subsequently tested against two cancer cell lines, MCF-7 and
SK-MEL-28 cells (melanoma cell line) in a clonogenic-type assay. These cell lines were chosen to cover
different origins of cancer as MCF-7 are epithelial based and the SK-MEL-28 cells are from neural
crest. NFF cells were also tested to represent normal cells with a doubling time similar to cancer
cell lines. Variation was observed in activity between the fractionated venoms, and is consistent
with venom component variations between spiders as shown previously for related species [5,17].
Despite this variation, all eight species showed early eluting fractions in the RP-HPLC chromatograms
that demonstrated activity against the MCF-7 breast cancer cell line.
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Figure 1. Cytotoxicity of Phlogius sp. crude venom and a purified component, PA366. (A) Dose 
response for cytotoxic cell killing by Phlogius sp. crude venom compared to vehicle. Crude venom 
(squares) or vehicle (circles) was incubated with MCF-7 breast cancer cells at the indicated volumes 
for 5 days, before assay for cell survival using the sulforhodamine B (SRB) assay. Cell survival 
percentages normalised to untreated cells are indicated. (B) Dose response for cytotoxic cell death of 
PA366 compared to vehicle in MCF-7, SK-MEL-28 or NFF cells. Cells were treated with the indicated 
concentrations of purified PA366 for 5 days, before assay for cell survival using SRB. Cell survival 
percentages normalised to untreated cells are indicated. Representative data from a single experiment 
with triplicate readings are shown. 
Table 1. Spider venoms with cytotoxic activity and the presence or absence of two polyamines a. 
Species PA366 PA389 
Acanthoscuria geniculata ×  
Ceratogyrus darlingi  × 
Chilobrachy penang ×  
Histerocrastes gigas   
Nhandu chromatus   
Phlogius sp. ×  
Psalmopoeus irminia ×  
Atrax robustus  × 
a Crude venoms were screened for the presence of PA366 or PA389 using NMR spectroscopy. 
Due to the availability of suitable quantities of the Phlogius sp. spider venom, this species was 
chosen for larger scale purification and characterisation of the active component(s). The active 
fractions from the Phlogius sp. spider venom were analysed using mass spectrometry and analytical 
RP-HPLC, and shown to contain a single major component. This purified component, termed PA366, 
was tested for activity in the clonogenic-type assays. PA366 showed activity against MCF-7 cells, and 
limited activity against the SK-MEL-28 and primary NFF cells when compared to vehicle controls as 
shown in Figure 1B. 
PA366 is highly hydrophilic and is one of the first peaks of crude Phlogius sp. spider venom to 
elute from a C18 RP-HPLC column (Figure 2A). Analysis of the homonuclear and heteronuclear NMR 
data of PA366 indicated the presence of a ring structure connected to a spermine polyamine tail, as 
shown in Figure 2B. This structure was elucidated based on correlations observed in the HSQC, 
Figure 1. Cytotoxicity of Phlogius sp. crude venom and a purified component, PA366. (A) Dose response
for cytotoxic cell killing by Phlogius sp. crude venom compared to vehicle. Crude venom (squares) or
vehicle (circles) was incubated with MCF-7 breast cancer cells at the indicated volumes for 5 days, before
assay for cell survival using the sulforhodamine B (SRB) assay. Cell survival percentages normalised to
untreated cells are indicated. (B) Dose response for cytotoxic cell death of PA366 compared to vehicle in
MCF-7, SK-MEL-28 or NFF cells. Cells were treated with the indicated concentrations of purified PA366
for 5 days, before assay for cell survival using SRB. Cell survival percentages normalised to untreated
cells are indicated. Representative data from a single experiment with triplicate readings are shown.
Table 1. Spider venoms with cytotoxic activity and the presence or absence of two polyamines a.
Species PA366 PA389
Acanthoscuria geniculata ×
Ceratogyrus darlingi ×
Chilobrachy pe ang ×
Histe ocra tes gigas
Nhandu chromatus
Phlogius sp. ×
Psalmopoeus irminia ×
Atrax robustus ×
a Crude venoms were screened for the presence of PA366 or PA389 using NMR spectroscopy.
Due to the availability of suitable quantities of the Phlogius sp. spider venom, this species was
chosen for larger scale purification and characterisation of the active component(s). The active fractions
from the Phlogius sp. spider venom were analysed using mass spectrometry and analytical RP-HPLC,
and shown to contain a single major component. This purified component, termed PA366, was tested
for activity in the clonogenic-type assays. PA366 showed activity gainst MCF-7 cells, and limited
activity ag inst he SK-MEL-28 and prim ry NFF cells when compared to vehicle controls as shown in
Figure 1B.
PA366 is highly hydrophilic and is one of the first peaks of crude Phlogius sp. ider venom to elute
from a C18 RP-HPLC column (Figure 2A). Analysis of the homonuclear and heteronuclear NMR data
of PA366 indicated the presence of a ring structure connected to a spermine polyamine tail, as shown
in Figure 2B. This structure was elucidated based on correlations observed in the HSQC, HMBC and
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HSQC-TOCSY spectra, and coupling constants and chemical shifts measured from one-dimensional
1H spectra. The multiplicities of the 1H NMR signals are reported as: d, doublet; t, triplet; p, pentet;
m, multiplet; br, broad. Coupling constants (J values) are reported in hertz (Hz). HRMS: calculated
for C19H34N4O3 [M + H]+ 367.2631, found 367.2653. 1H NMR (600 MHz, H2O/10% D2O): δ 8.06
(1H, br t, J = 6.21 Hz, H*), 7.16 (2H, d, J = 8.71 Hz, Hb), 6.85 (2H, d, J = 8.71 Hz, Ha), 4.41 (1H, t,
J = 5.96 Hz, Hd), 3.31–3.25 (2H, m, He), 3.20–3.08 (6H, m, Hn, Hh, Hl), 3.02–2.93 (4H, m, Hc, Hk), 2.73
(2H, br t, J = 8.72 Hz, Hg), 2.08 (2H, br p, Hm), 1.78–1.71 (6H, br m, Hi, Hj, Hf). 13C NMR (150 MHz,
H2O/10% D2O): δ 179.0, 156.7, 133.3 (2C), 130.7, 118.3 (2C), 73.7, 48.8, 48.6, 46.7, 46.2, 40.4, 38.4,
37.4, 27.1, 25.5, 24.3 (2C). The proton assignments are displayed on the one-dimensional spectrum in
Figure 3. MS/MS fragmentation resulted in two primary fragment ions of m/z 129.26 and m/z 293.37,
consistent with fragmentation at the sites labelled in Figure 2B. Other fragment ions were also evident
including m/z 58.15, m/z 112.23 and m/z 222.28, and are consistent with the fragmentation patterns
observed in similar molecules [18]. The theoretical calculated mass for the derived structure of PA366
is 366.2631 Da, and a m/z 367.2653 (exact mass 366.2573 Da) was observed by MALDI-MS in reflector
positive ion mode.
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Figure 2. Characterisation of spider venom polyamines. (A) RP-HPLC chromatogram of crude female 
Phlogius sp. venom with the peak corresponding to the polyamine PA366 highlighted in red (Thermo 
Scientific Hypersil GOLD aQ 250 × 10mm, 5µm column; 1 mL/min flow rate; Solvent A H2O/0.05% 
TFA, Solvent B 90% ACN/H2O/0.045% TFA; 5–80% solvent B in 75 min, 80–90% solvent B in 5 min, 
90% solvent B for 5 min, and 90–5% solvent B in 2 min; absorbance at 214 nm); (B) SCIEX TOF/TOF™ 
5800 MALDI MS/MS spectrum of PA366 using CHCA matrix, and the determined chemical structure 
with relevant fragment ions highlighted; (C) RP-HPLC chromatogram of crude female A. robustus 
venom with the peak corresponding to the polyamine PA389 highlighted in red (Thermo Scientific 
Hypersil GOLD aQ 250 × 10mm, 5µm column; 1 mL/min flow rate; Solvent A H2O/0.05% TFA, Solvent 
B 90% ACN/H2O/0.045% TFA; 5–80% solvent B in 75 min, 80–90% solvent B in 5 min, 90% solvent B 
for 5 min, and 90–5% solvent B in 2 min; absorbance at 214 nm); (D) SCIEX TOF/TOF™ 5800 MALDI-
MS/MS spectrum of PA389 using CHCA matrix, and the determined chemical structure with relevant 
fragment ions highlighted. 
Figure 2. Characterisation of spider venom polyamines. (A) RP-HPLC chromatogram of crude female
Phlogius sp. venom with the peak corresponding to the polyamine PA366 highlighted in red (Thermo
Scientific Hypersil GOLD aQ 250 × 10 mm, 5 µm column; 1 mL/min flow rate; Solvent A H2O/0.05%
TFA, Solvent B 90% ACN/H2O/0.045% TFA; 5–80% solvent B in 75 min, 80–90% solvent B in 5 min,
90% solvent B for 5 min, and 90–5% solvent B in 2 min; absorbance at 214 nm); (B) SCIEX TOF/TOF™
5800 MALDI MS/MS spectrum of PA36 using C CA atrix, and the determined chemical structure
with relevant fragment ions highlighted; (C) - chro atogram of crude female A. robustus
venom with the peak corresponding to the polya i ighlighted in red (Thermo Scientific
Hypersil GOLD aQ 250 10 m, 5 µm column; 1 L/min flow rat ; Solvent A H2O/0.05% TFA,
Solvent B 90% ACN/H2O/0.045% TFA; 5–80% solvent B in 75 min, 80–90% solve t B in 5 mi , 90%
solvent B for 5 min, and 90–5% solvent B in 2 min; absorbance at 214 nm); (D) SCIEX TOF/TOF™ 5800
MALDI-MS/MS spectrum of PA389 using CHCA ma rix, and the deter ined chemical structure with
relevant fragment ions ighlighted.
Toxins 2017, 9, 346 5 of 13Toxins 2017, 9, 346  5 of 13 
 
 
Figure 3. Chemical structure and 1H NMR spectrum of PA366. The assignments were derived based 
on two-dimensional NMR spectra and confirmed using mass spectrometry fragmentation analysis. 
2.2. NMR Screening of Crude Spider Venoms 
Following the characterisation of purified PA366, crude venom from the seven other spiders that 
showed early eluting fractions with cytotoxic activity were analysed using one-dimensional NMR 
spectroscopy to screen for the presence of PA366. The one-dimensional NMR spectra of selected 
examples are shown in Figure 4. Although spider venoms have numerous disulfide-rich peptides, 
the small molecules have sharper peaks in the 1D spectra, making them easily discernible from 
peptide signals. This analysis confirmed the presence of PA366 in the crude venom from the spider 
species Acanthoscuria geniculata, Chilobrachys penang, and Psalmopoeus irminia, in addition to the 
Phlogius sp. 
Analysis of the NMR spectra of the crude venom of Ceratogyrus darlingi and A. robustus indicated 
they do not contain PA366, despite demonstrating cytotoxic activity in the assays. The lack of PA366 
was confirmed by mass spectrometry analysis, and instead a mass of 389 Da was present. The 
structure of this active component in A. robustus venom was determined following further 
purification by RP-HPLC, and subsequent analysis using NMR spectroscopy and MS/MS. The 
analysis determined that A. robustus venom contains a polyamine previously characterised from the 
venom of a trap-door spider (Hebestatis theveniti) and a tarantula (Harpactirella sp.), and termed Het389 
[19]. Subsequent analysis of the C. darlingi venom also confirmed the presence of Het389. Given the 
presence of Het389 across multiple genera, we suggest the new identifying term PA389 is more 
appropriate. The structure of PA389 is shown in Figure 2D and the 1D NMR spectra in Figure 4. The 
theoretical calculated exact mass for PA389 is 389.2791 Da, and a m/z 390.2443 (exact mass 389.2364 Da) 
was observed by MALDI-MS in reflector positive ion mode. In comparison to the hydroxyphenyl 
based head group in PA366, PA389 has an indole head group and identical spermine tail. The 
cytotoxicity of PA389 is shown in Figure 5 and shows this polyamine only displays cytotoxicity at 
millimolar concentrations. 
3. he ical structure and 1H NMR spectrum of PA366. The assignments were d rived based on
two-dimensional NMR spectra and confirmed using mass spectrometry f agmentation analysis.
. . ree i f r e i er e o s
ll i t t i ti f rifie A366, f t t i t t
l l ti f ti it c t t i ti it r a l s si one- i i l
t t scre for the presence of PA366. - i i l t f s l t
l i i 4. lt i i lfi - i ti ,
t small molecules have sharper peaks in the 1D spectra, making them easily discernible from peptide
signals. This analysis confirmed the presence of PA366 in the crude venom from the spider speci s
Acanthoscuria geniculata, Chilobr chys penang, and Psalmopoeus irminia, in addition to the Phlogius sp.
Analysis of the NMR spectra of the crude venom of Ceratogyrus darlingi and A. robustus indicated
they do not contain PA366, despite demonstrating cytot xic activity in the assays. The lack of PA366 was
confirmed by mass spectrom try analysis, and i stead a mass of 389 Da was present. The structure of
this active component in A. robustus venom was determined following further purification by RP-HPLC,
and s bsequent analysis using NMR spectroscopy and MS/MS. The analysis determined t at
A. robustus venom contains a polyamin pr viously characterised from the venom of trap-door spider
(Hebestatis theveniti) and a tarantula (Harpactirella sp.), and termed Het389 [19]. Subsequent analysis
of the C. darlingi venom also confirmed the prese ce of Het389. Given the presence of Het389 across
multiple genera, we suggest t e new identifying term PA389 is more a propriate. The structure of
PA389 is sh wn in Figure 2D and the 1D NMR spectra in Figure 4. The theoretical calculated exact ass
for PA389 is 389.2791 Da, and a m/z 390.2443 (exact mass 389.2364 Da) was observed by MALDI-MS in
reflector positive ion mode. In comparison to the hydroxyphenyl based head group in PA366, PA389
has an indole head group and identical spermine tail. The cytotoxicity of PA389 is shown in Figure 5
and shows this polyamine only displays cytotoxicity at millimolar concentrations.
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in Figure 6. The NMR spectra of A. geniculata is dominated by PA366, whereas P. antinous shows no 
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based on the large number of peaks and significant peak dispersion in the 6–9.5 ppm range. These 
peptides are likely to be disulfide-rich based on previous analyses of spider venoms [20]. 
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geniculata. 1H NMR analysis of the crude venom from P. antinous shows a composition that is 
primarily peptides, based on the number of peaks and dispersion in the amide region; this venom 
does not show any evidence of cytotoxicity against MCF-7, SK-MEL-28 or NFF cells. In contrast, the 
spectrum of cytotoxic crude venom from A. geniculata is dominated by the peaks corresponding to 
PA366. 
Figure 5. Cytotoxicity of PA389 against cancer cell lines. Dose response for cytotoxic cell killing of PA389
in MCF-7 (circles) or SK-MEL-28 (squares) cells. Cells were treated with the indicated concentrations
of purified PA389 for five days, before assay for cell survival was assessed using SRB. Cell survival
percentages normalised to untreated cells are indicated. Representative data from a single experiment
with triplicate readings are shown.
The venom from H. gigas and N. chromatus did ot appear to contain either PA366 or PA389,
despite displaying cytotoxic ctivity. H. gigas appears to contain primarily peptide ba ed molecules,
whereas the pect from N. chromatus is dominated by small molecules but with different shifts
to the olyamines characterised in this study. Comparison of the 1D spectra of A. eniculata and
Pamphobeteus antinous, a tarantula species that did not display cytotoxic activity, highlights the
differences in the venom NMR “profiles” in the presence and absence of small molecules, as shown
in Figure 6. The NMR spectra of A. geniculata is dominated by PA366, whereas P. antinous shows
no evidence of small molecules. Instead, the venom of P. antinous appears to contain primarily
peptides based on the large number of peaks and significant peak dispersion in the 6–9.5 ppm range.
These peptides are likely to be disulfide-rich based on previous analyses of spider venoms [20].
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Figure 6. One-dimensional NMR spectra of selected crude spider venoms from P. antinous and
A. geniculata. 1H NMR analysis of the crude venom from P. antinous shows a composition that is
primarily peptides, based on the number of peaks and dispersion in the amide region; this venom
does not show any evidence of cytotoxicity against MCF-7, SK-MEL-28 or NFF cells. In contrast,
the spectrum of cytotoxic crude venom from A. geniculata is dominated by the peaks corresponding
to PA366.
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2.3. Protein Array Analysis
A sample of PA366 was biotinylated for protein array analysis to identify any protein binding
interactions. Biotinylated PA366 was shown by MS analysis to have a molecular weight of 706 Da,
confirming biotin binding to the primary amine at the end of the polyamine chain. Analysis of the
biotinylated PA366 binding to a human protein array demonstrated interaction with numerous proteins,
presumably via non-specific interactions. Signals with Z-scores above three were considered to be
significant. The polyamine bound to MAPK1 and MAP3K2; both giving Z-scores of 3.7. These proteins
have previously been shown to have roles in tumour development and breast cancer [21]. The protein
with the highest score however, based on the signal intensity, was a zinc finger protein (ZNF501
Z-score 13.93).
3. Discussion
In the current study, we have used NMR spectroscopy and MS to characterise the novel polyamine
PA366, which has selective cytotoxicity for MCF-7 breast cancer cells. Comparison with a related
polyamine, PA389, provided insight into the important structural features. The two polyamines
consist of a spermine tail functionalised with an aromatic head group, and are identical except
PA366 has a 2-hydroxy-3-(4-hydroxyphenyl)propanal aromatic head group, while PA389 contains
a 2-hydroxy-3-(1H-indol-3-yl)propanal based head group. PA389 only displays cytotoxicity at
high concentrations in contrast to PA366, indicating that the aromatic head group is important
for cytotoxicity.
Using ProtoArray technology, analysis of the protein binding properties of PA366 indicates
non-specific binding to a range of proteins. However, the protein with the highest Z-score in the
protein array analysis, which is likely to have the most significant interaction, is zinc finger protein 501,
which belongs to the Krüppel-like c2h2 type zinc finger protein family. Zinc finger proteins are one of
the most common families of DNA-binding transcription factors [22] and a recent study suggested they
can be involved in tumour development [21]. Interestingly, the mammalian polyamines putrescine,
spermidine and spermine alter binding of DNA to zinc finger transcription factors [23], which is
consistent with a role for zinc finger protein 501 in the bioactivity of PA366. However, additional
interactions might also be involved given that MAPK1 and MAP3K2, mitogen-activated protein
kinases (MAPK), were also significant hits in the ProtoArray analysis. Several MAPK genes are
associated with breast cancer [24], and activation of MAPK can lead to cell proliferation, invasion and
metastasis, making these kinases potential targets for cancer treatment [25,26]. To provide greater
insight into the possible targets of PA366 it is important to determine the membrane permeability,
which will influence the targets accessible to the molecule.
The cytotoxicity we observed for PA366 is consistent with the role of mammalian polyamines
in cell death. Numerous links have been identified between mammalian polyamines and apoptotic
pathways. For example, the production of hydrogen peroxide produced during polyamine catabolism
is thought to be involved in cell death [27]. However, alteration in polyamine levels can have an impact
on numerous cellular functions such as DNA-protein interactions, protein-protein interactions and
mitochondrial integrity which can lead to cell death. Morphological analysis of the cells following
incubation with PA366 indicates the presence of apoptosis but further study is required to confirm
this hypothesis.
Although PA366 displays cytotoxicity against a cancer cell lines, this is unlikely to be related to
its function in the spider venom. The primary target of venom polyamine toxins is thought to be the
ionotropic glutamate receptors [28]. PA389 has previously been shown to cause rapid but reversible
paralysis to lepidopteran insect larvae, suggesting a role in prey capture [19]. Given the structural and
functional similarities between PA389 and PA366, it is likely that the latter also displays some form of
bioactivity against insect prey.
The known distribution of PA366 and PA389 determined from previous work and this study is
shown in the phylogenetic tree in Figure 7. PA366 is present in a range of geographically diverse spider
Toxins 2017, 9, 346 9 of 13
species from the family Theraphosidae, indicating that differences such as diet and environmental
conditions are unlikely to influence the production of this polyamine. Similarly, PA389 is present
in the venom of spiders from the Theraphosidae family, but also in the venom of species from the
Hexathelidae and Ctenizidae families. In this study, we have confirmed the presence of PA389 in
the venom of the Sydney Funnel-web spider, Atrax robustus, as the undefined 3-(3-indoyl)lactic
acid and spermine complex suggested by Sutherland [29] and proposed as identical to PA389 by
Skinner et al. [19]. It is likely that PA366 is also present in other spider families but further analysis is
required to confirm this hypothesis.
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Figure 7. Phylogenic tree of some spider venoms showing the distribution of PA366 and PA389.
A phylogenetic tree of crude spider venoms that demonstrated cytotoxicity on MCF-7 or
SK-MEL-28 cells in this study, and the presence of the polyamines PA366 and PA389. The two
spider species, Hebestatis theveneti and Harpactirella sp., from the original identification and
characterisation study of PA389 are also included [19] (Photograph credits: Acanthoscurria geniculata,
Ceratogyrus darlingi, Harpactirella sp., Hysterocrates gigas, and Nhandu chromatus—Bastian
Rast; Chilobrachys penang—Muhammad Ashraf; Psalmopoeus irmi ia Edward Eva s;
Hebestatis theveneti—Marshal Hedin; Phlogius sp. and Atrax robustus—David Wilson).
One outcome of this study is NMR spectroscopy proved an effective way of screening and
detecting the presence of the polyamines PA366 and PA389 without the need for fractionation of the
venom. Although the spider venoms contain a large number of disulfide-rich peptides, the polyamines
have low molecular weights and provide much sharper spectral peaks, and can be detected when
only low microgram amounts of material are present in contrast to the larger peptides. This type
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of NMR spectroscopy screening has also been shown to be useful for the discovery of new small
molecules from other sources. For example, unfractionated extracts from insects examined using
2D NMR spectroscopy led to the discovery of tricyclic pyrones from a ladybird beetle including the
identification of ring systems that had not previously been found in nature [1].
Despite the conservation of PA366 in several venoms, our study also serves to highlight the
compound diversity and broad range of biological activities found in spider venom. N. chromatus has
early eluting peaks from RP-HPLC that display cytotoxicity but the venom does not appear to contain
PA366 or PA389. The 1D NMR spectrum indicates the presence of small molecules, and it is likely there
are several, related polyamines that might account for our observed activity. Although there is evidence
of small molecules in the crude venom of H. gigas, the venom is dominated by peptides/proteins
in contrast to the venoms such as Phlogius sp., A. robustus and C darlingi. Furthermore, P. antinous
appears to show only peptide related peaks in the amide region, and does not display cytotoxicity.
This compound and bioactivity diversity is one of the features that has led to the extensive study of
spider venom for the discovery of novel compounds for therapeutic or agricultural applications [20].
In summary, we have shown that a spider venom polyamine can have relatively selective
cytotoxicity activity against specific cancer cell lines and that the aromatic head group appears to be
involved in conferring cytotoxicity. Insight into the distribution of spider venom polyamines across
species and genera has also been gained from screening using NMR spectroscopy.
4. Materials and Methods
4.1. Venom Collection and Purification
A majority of the crude venoms were purchased from the commercial supplier Alphabiotoxine
Laboratory, Montroeul-au-bois, Hainaut, Belgium. Crude venom from Pterinochilus meridionalis,
Vitalius roseus and Hogna carolinensis was purchased from SpiderPharm, Yarnell, AZ, USA. Crude
venom was also collected from a colony of housed specimens of female Australian tarantulas (Phlogius
sp. and Coremiocnemis tropix), Macrothele gigas, and Poecilotheria fasciata and Poecilotheria metallica by
electrostimulation of the venom glands. Male Sydney funnel-web spider (Atrax robustus) venom
(~5 mg) was supplied by the Australian Reptile Park (Gosford, NSW, Australia). Crude venom
was fractionated by reversed-phase HPLC (RP-HPLC) using an Agilent 1260 Infinity HPLC system
(Agilent, Santa Clara, CA, USA) and a Thermo Scientific Hypersil GOLD aQ (250 × 10 mm, 5 µm)
column (Thermo Fisher Scientific, Waltham, MA, USA). Fractionation of the venom components was
achieved using a linear gradient of two mobile phases: H2O/0.05% trifluoroacetic acid (TFA; Auspep,
Tullamarine, VIC, Australia) [solvent A], and 90% acetonitrile (ACN; Sigma-Aldrich, St. Louis, MO,
USA)/H2O/0.045% TFA [solvent B]. Separation used a gradient of 5–80% solvent B in 75 min, 80–90%
solvent B in 5 min, 90% solvent B for 5 min, and 90–5% solvent B in 2 min at a flow rate of 6 mL/min.
Venom component elution was monitored at 214 nm and 1 min fractions were collected.
4.2. Cytotoxicity Assays
All cells were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated foetal
calf serum (Life Technologies, Carlsbad, CA, USA) in RPMI-1640 medium supplemented with
100 U/mL penicillin, 100 µg/mL streptomycin, and 3 mM HEPES at 5% CO2, 99% humidity at
37 ◦C. Routine mycoplasma tests were performed using Hoechst stain or PCR and were always
negative. The cytotoxicity of compounds was determined using clonogenic survival assays of MCF-7
(breast adenocarcinoma), SK-MEL-28 (melanoma) and human neonatal foreskin fibroblasts (NFF)
cells [30,31]. The cell lines were purchased from ATCC. Cells were plated into 96-well microtitre
plates at 5 × 103 cells/well, and allowed to adhere overnight. Compounds were added to culture
medium at the indicated final concentrations, and plates incubated under the above conditions for
five days. Cell survival was then assayed using sulforhodamine B (SRB; Sigma, St. Louis, MO, USA).
Briefly, the culture medium was removed from the 96-well microtitre plates and the plates washed
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twice with phosphate buffered saline (PBS), before the cells were fixed with methylated spirits for
15 min. The plates were then rinsed with tap water and the fixed cells stained with 50 µL/well of
SRB solution (0.4% sulforhodamine B (w/v) in 1% (v/v) acetic acid) over a period of 1 h. The SRB
solution was removed from the wells and the plates rapidly washed two times with 1% (v/v) acetic
acid. Protein bound dye was then solubilised with the addition of 100 µL of 10 mM unbuffered
Tris, and incubated for 15 min at 25 ◦C. Plates were then read at 564 nm on a VERSA max tuneable
microplate reader (Molecular Devices, Sunnyvale, CA, USA). Negative (vehicle only) and positive
(cisplatin) controls were run with every cell survival experiment to ensure the quality of the data.
Vehicle only control results in <5% change in cell survival whereas the positive control inhibited cell
survival at nanomolar concentrations as expected.
4.3. Mass Spectrometry and NMR Analysis
1H NMR and 13C NMR spectra were recorded at 600.13 MHz and 150.91 MHz at 298 K on a
Bruker Avance III 600 MHz spectrometer (Bruker, Billerica, MA, USA) equipped with a cryoprobe.
Samples were dissolved in 90% H2O/10% D2O (v/v) (100 µM). D2O (99.9%) was obtained from
Cambridge Isotope Laboratories, Woburn, MA, USA for 1H NMR measurements. Spectra were
referenced to 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS; Cambridge Isotope Laboratories,
Woburn, MA, USA). Two-dimensional spectra included TOCSY, NOESY, DQF-COSY, HSQC, HMBC
and HSQC-TOCSY. TOCSY and NOESY mixing times of 80 ms and 500 ms respectively were used.
Spectra were analyzed using TOPSPIN (Bruker, Billerica, MA, USA).
Mass spectrometry (MS) was performed using a SCIEX TOF/TOF™ 5800 MALDI, and high
resolution mass spectrometry (HRMS) using direct infusion on a SCIEX QSTAR Elite equipped
with a nanospray (SCIEX, Framingham, MA, USA). MALDI-MS samples were spotted on 384-well
stainless steel target plates using 0.5 µL of sample and 0.5 µL of either α-cyano-4-hydroxycinnamic
acid (CHCA; Sigma-Aldrich, St. Louis, MO, USA) matrix at 7.5 mg/mL in 50% ACN/0.1% TFA,
or 2,5-dihydroxybenzoic acid (DHB; Sigma-Aldrich, St. Louis, MO, USA) matrix at 10 mg/mL in
50% ethanol/0.1% TFA. Calibration was performed before spectra collection for each sample using
Calibration Mix solution 2 (SCIEX, Framingham, MA, USA). Spectra were acquired in reflector positive
ion mode from m/z 300 to 1000 Da, and averaged over 2000 laser shots. QSTAR Elite MS samples were
infused at 2 µL/min. MS spectra were acquired in positive ion mode from m/z 200 to 1000 Da and
spectra were externally calibrated using SCIEX renin standard. MS/MS spectra were acquired for
the product ions 367.26 Da and 390.2 Da from m/z 10 to 500 Da. All spectra were acquired with an
accumulation time of 1 s, using an ion-spray voltage of 3700 V, a declustering potential of 80 V, and a
focussing potential of 280 V.
4.4. Protein Array Analysis
Biotinylation of PA366 for protein interaction analysis was achieved utilising a 20-fold excess of
EZ-Link® Sulfo-NHS-LC-biotin (ThermoFisher Scientific, Waltham, MA, USA), and following the
manufacturer’s instructions. Successful labelling of PA366 was confirmed by molecular weight analysis
using a SCIEX TOF/TOF™ 5800 mass spectrometer (SCIEX, Framingham, MA, USA), followed by
RP-HPLC purification of labelled PA366 to remove excess non-reacted and hydrolyzed biotin reagent
from the solution. The purified sample was dried and resuspended in 100 µL of 1.0% PBS (pH 7.2)
to achieve a required final amount of 10 µg. Interactions between biotinylated PA366 and more than
9000 human proteins were investigated employing a ProtoArray® Human Protein Microarray v5.0
Protein-Protein Interaction (PPI) kit (Invitrogen™, Carlsbad, CA, USA), and significant interactions
detected using a GenePix® 4000Bmicroarray scanner (Molecular Devices, Sunnyvale, CA, USA),
according to the manufacturer’s instructions.
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